Updated Jul 16, 2026 · Last SEC filing 2026-07-02
Nurix Therapeutics, Inc. (NRIX) has filed 18 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-02. 4 Form 8-K material event filings were reported by NRIX in the last 90 days. 7 Form 144 notices of proposed sale were filed for NRIX stock. InsiderAlpha tracks every NRIX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001549595 |
|---|
| Form 4 filings (90d) | 18 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Form 144 notices (90d) | 7 |
| Latest Form 4 filing | 2026-07-02 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Ring Christine | Chief Legal Officer | S — Open-market sale | 11.0K | $23.56 | $259K | SEC | |
| Ring Christine | Chief Legal Officer | M — Option exercise | 5.2K | $1.86 | $10K | SEC | |
| Ring Christine | Chief Legal Officer | M — Option exercise | 5.8K | $8.72 | $50K | SEC | |
| Hansen Gwenn | Chief Scientific Officer | S — Open-market sale | 5.4K | $20.00 | $108K | SEC | |
| Ring Christine | Chief Legal Officer | M — Option exercise | 15.6K | $8.72 | $136K | SEC | |
| Ring Christine | Chief Legal Officer | M — Option exercise | 13.3K | $7.26 | $97K | SEC | |
| Ring Christine | Chief Legal Officer | S — Open-market sale | 28.9K | $20.06 | $581K | SEC | |
| Ring Christine | Chief Legal Officer | M — Option exercise | 3.4K | $1.86 | $6K | SEC | |
| Ring Christine | Chief Legal Officer | S — Open-market sale | 8.1K | $16.60 | $135K | SEC | |
| van Houte Hans | Chief Financial Officer | S — Open-market sale | 13.5K | $16.58 | $223K | SEC | |
| van Houte Hans | Chief Financial Officer | S — Open-market sale | 582 | $17.18 | $10K | SEC | |
| Ring Christine | Chief Legal Officer | S — Open-market sale | 8.1K | $16.96 | $138K | SEC | |
| Ring Christine | Chief Legal Officer | S — Open-market sale | 5.4K | $16.76 | $90K | SEC | |
| Ring Christine | Chief Legal Officer | M — Option exercise | 2.9K | $0.00 | — | SEC | |
| Ring Christine | Chief Legal Officer | M — Option exercise | 3.8K | $0.00 | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Nurix Therapeutics, Inc. (NRIX). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Ring Christine | 22 | $1.56M |
| van Houte Hans | 9 | $273K |
| Hansen Gwenn | 8 | $161K |
| GREGORY JULIA P | 1 | — |
| Reinsdorf Judith A | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in NRIX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live NRIX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.